全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

eif4e在非小细胞肺癌耐药性中的作用

Keywords: 非小细胞肺癌,eif4e,厄洛替尼,耐药性,egfr

Full-Text   Cite this paper   Add to My Lib

Abstract:

探讨eif4e对厄洛替尼耐药细胞株细胞增殖的影响及作用机制.在配对的厄洛替尼敏感和耐药细胞株(hcc827-ep、hcc827-er)上,采用实时定量pcr检测mrna水平的变化,westernblot检测蛋白水平的变化;通过srb检测细胞的生长和药物的抑制率的变化.以及用脂质体转染eif4e的小干扰rna,用上述方法检测多种信号分子mrna、蛋白水平的变化,及对细胞生长和对药物抑制率的影响.结果显示,与hcc827-ep相比,eif4e在hcc827-er上高表达;hcc827

References

[1]  cappuzzof,ciuleanut,stelmakhl,etal.erlotinibasmaintenancetreatmentinadvancednon-small-celllungcancer:amul-ticentre,randomised,placebo-controlledphase3study[j].thelancetoncology,2010,11(6):521-529.
[2]  goodfellowig,robertslo.eukaryoticinitiationfactor4e[j].theinternationaljournalofbiochemistryandcellbiology,2008,40(12):2675-2680.
[3]  debenedettia,graffjr.eif-4eexpressionanditsroleinmalignanciesandmetastases[j].oncogene,2004,23(18):3189-3199.
[4]  graffjr,konicekbw,carterjh,etal.targetingtheeukaryotictranslationinitiationfactor4eforcancertherapy[j].cancerresearch,2008,68(3):631-634.
[5]  thummasc,kratzkera.translationalcontrol:atargetforcancertherapy[j].cancerletters,2007,258(1):1-8.
[6]  maz,zhul,luox,etal.perifosineenhancesmtorc1-targetedcancertherapybyactivationofgsk3βinnsclccells[j].cancerbiologyandtherapy,2012,13(11):1009-1017.
[7]  mathisjm,williansbj,sibleyda,etal.cancer-specifictargetingofanadenovirus-deliveredherpessimplexvirusthymidinekinasesuicidegeneusingtranslationalcontrol[j].thejournalofgenemedicine,2006,8(9):1105-1120.
[8]  nowakde,tianb,jamaluddinm,etal.relaser276phosphorylationisrequiredforactivationofasubsetofnf-κb-dependentgenesbyrecruitingcyclin-dependentkinase9/cyclint1complexes[j].molecularandcellularbiology,2008,28(11):3623-3638.
[9]  zhoubbs,peytonm,heb,etal.targetingadam-mediatedligandcleavagetoinhibither3andegfrpathwaysinnon-smallcelllungcancer[j].cancercell,2006,10(1):39-50.
[10]  paow,millerva,politika,etal.acquiredresistanceoflungadenocarcinomastogefitiniborerlotinibisassociatedwithasecondmutationintheegfrkinasedomain[j].plosmedicine,2005,2(3):e73.
[11]  cheng,kronenbergerp,teugelse,etal.effectofsirnastargetingtheegfrt790mmutationinanon-smallcelllungcancercelllineresistanttoegfrtyrosinekinaseinhibitorsandcombinationwithvariousagents[j].biochemicalandbiophysicalresearchcommunications,2013,431(3):623-629.
[12]  maheswarans,sequistlv,nagraths,etal.detectionofmutationsinegfrincirculatinglung-cancercells[j].newenglandjournalofmedicine,2008,359(4):366-377.
[13]  kobayashis,boggontj,dayaramt,etal.egfrmutationandresistanceofnon-small-celllungcancertogefitinib[j].newenglandjournalofmedicine,2005,352(8):786-792.
[14]  rosenwaldib.theroleoftranslationinneoplastictransformationfromapathologist爷spointofview[j].oncogene,2004,23(18):3230-3247.
[15]  coquereto.linkingcyclinstotranscriptionalcontrol[j].gene,2002,299(1):35-55.
[16]  inabat,matsushimeh,valentinem,etal.genomicorganization,chromosomallocalization,andindependentexpressionofhumancyclindgenes[j].genomics,1992,13(3):565-574.
[17]  jemala,siegelr,warde,etal.cancerstatistics,2008[j].ca:acancerjournalforclinicians,2008,58(2):71-96.
[18]  ferlayj,shinhr,brayf,etal.estimatesofworldwideburdenofcancerin2008:globocan2008[j].internationaljournalofcancer,2010,127(12):2893-2917.
[19]  kosakat,yamakie,mogia,etal.mechanismsofresistancetoegfrtkisanddevelopmentofanewgenerationofdrugsinnon-small-celllungcancer[j/ol].biomedresearchinternational,2011:7[2011-04-11].http://dx.doi.org/10.1155/2011/165214.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133